Literature DB >> 9832502

Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1.

R M Zwijsen1, R S Buckle, E M Hijmans, C J Loomans, R Bernards.   

Abstract

The estrogen receptor (ER) is an important regulator of growth and differentiation of breast epithelium. Transactivation by ER depends on a leucine-rich motif, which constitutes a ligand-regulated binding site for steroid receptor coactivators (SRCs). Cyclin D1 is frequently amplified in breast cancer and can activate ER through direct binding. We show here that cyclin D1 also interacts in a ligand-independent fashion with coactivators of the SRC-1 family through a motif that resembles the leucine-rich coactivator binding motif of nuclear receptors. By acting as a bridging factor between ER and SRCs, cyclin D1 can recruit SRC-family coactivators to ER in the absence of ligand. A cyclin D1 mutant that binds to ER but fails to recruit coactivators preferentially interferes with ER activation in breast cancer cells that have high levels of cyclin D1. These data support that cyclin D1 contributes significantly to ER activation in breast cancers in which the protein is overexpressed. Our present results reveal a novel route of coactivator recruitment to ER and establish a direct role for cyclin D1 in regulation of transcription.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832502      PMCID: PMC317237          DOI: 10.1101/gad.12.22.3488

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  53 in total

1.  Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.

Authors:  J P Renaud; N Rochel; M Ruff; V Vivat; P Chambon; H Gronemeyer; D Moras
Journal:  Nature       Date:  1995-12-14       Impact factor: 49.962

2.  Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor.

Authors:  E Kalkhoven; J E Valentine; D M Heery; M G Parker
Journal:  EMBO J       Date:  1998-01-02       Impact factor: 11.598

3.  Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.

Authors:  V Fantl; G Stamp; A Andrews; I Rosewell; C Dickson
Journal:  Genes Dev       Date:  1995-10-01       Impact factor: 11.361

4.  Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor.

Authors:  X Jacq; C Brou; Y Lutz; I Davidson; P Chambon; L Tora
Journal:  Cell       Date:  1994-10-07       Impact factor: 41.582

5.  Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1.

Authors:  E vom Baur; C Zechel; D Heery; M J Heine; J M Garnier; V Vivat; B Le Douarin; H Gronemeyer; P Chambon; R Losson
Journal:  EMBO J       Date:  1996-01-02       Impact factor: 11.598

6.  Cyclin D1 provides a link between development and oncogenesis in the retina and breast.

Authors:  P Sicinski; J L Donaher; S B Parker; T Li; A Fazeli; H Gardner; S Z Haslam; R T Bronson; S J Elledge; R A Weinberg
Journal:  Cell       Date:  1995-08-25       Impact factor: 41.582

7.  Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex.

Authors:  P D Jeffrey; A A Russo; K Polyak; E Gibbs; J Hurwitz; J Massagué; N P Pavletich
Journal:  Nature       Date:  1995-07-27       Impact factor: 49.962

8.  Sequence and characterization of a coactivator for the steroid hormone receptor superfamily.

Authors:  S A Oñate; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

9.  Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein.

Authors:  Y Sadovsky; P Webb; G Lopez; J D Baxter; P M Fitzpatrick; E Gizang-Ginsberg; V Cavailles; M G Parker; P J Kushner
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

10.  The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18.

Authors:  B Le Douarin; C Zechel; J M Garnier; Y Lutz; L Tora; P Pierrat; D Heery; H Gronemeyer; P Chambon; R Losson
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

View more
  89 in total

1.  Cdc25B functions as a novel coactivator for the steroid receptors.

Authors:  Z Q Ma; Z Liu; E S Ngan; S Y Tsai
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

2.  Differential control of transcription by DNA-bound cyclins.

Authors:  T Y Kim; W G Kaelin
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

3.  Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation.

Authors:  Jean-Bernard Lazaro; Peter J Bailey; Andrew B Lassar
Journal:  Genes Dev       Date:  2002-07-15       Impact factor: 11.361

4.  The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ERα, and is an independent prognostic factor in node-negative breast cancer.

Authors:  D J Brennan; D P O'Connor; H Laursen; S F McGee; S McCarthy; R Zagozdzon; E Rexhepaj; A C Culhane; F M Martin; M J Duffy; G Landberg; L Ryden; S M Hewitt; M J Kuhar; R Bernards; R C Millikan; J P Crown; K Jirström; W M Gallagher
Journal:  Oncogene       Date:  2011-12-05       Impact factor: 9.867

Review 5.  Regulating mitosis and meiosis in the male germ line: critical functions for cyclins.

Authors:  Debra J Wolgemuth; Shelby S Roberts
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-05-27       Impact factor: 6.237

6.  ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice.

Authors:  Mathew C Casimiro; Marco Crosariol; Emanuele Loro; Adam Ertel; Zuoren Yu; William Dampier; Elizabeth A Saria; Alex Papanikolaou; Timothy J Stanek; Zhiping Li; Chenguang Wang; Paolo Fortina; Sankar Addya; Aydin Tozeren; Erik S Knudsen; Andrew Arnold; Richard G Pestell
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

Review 7.  The estrogen receptor: a logical target for the prevention of breast cancer with antiestrogens.

Authors:  D A Tonetti; V C Jordan
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-10       Impact factor: 2.673

8.  Transcriptional regulation by a DNA-associated form of cyclin D1.

Authors:  Frédéric Bienvenu; Benjamin Barré; Sandrine Giraud; Sylvie Avril; Olivier Coqueret
Journal:  Mol Biol Cell       Date:  2005-01-19       Impact factor: 4.138

Review 9.  Cyclin D1, cancer progression, and opportunities in cancer treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  J Mol Med (Berl)       Date:  2016-10-02       Impact factor: 4.599

10.  Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.

Authors:  Michael A Augello; Craig J Burd; Ruth Birbe; Christopher McNair; Adam Ertel; Michael S Magee; Daniel E Frigo; Kari Wilder-Romans; Mark Shilkrut; Sumin Han; Danielle L Jernigan; Jeffry L Dean; Alessandro Fatatis; Donald P McDonnell; Tapio Visakorpi; Felix Y Feng; Karen E Knudsen
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.